Exercise-Responsive Endocrine, Metabolic and Immune Drug Targets: A Dual-Database Bibliometric and Knowledge-Mapping Analysis

Incretin-based pharmacotherapy — glucagon-like peptide-1 (GLP-1) receptor agonists, dual GIP/GLP-1 co-agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors — has reshaped the treatment of type 2 diabetes and obesity since 2005. Exercise acts on many of the same endocrine, metabolic and immune targets, yet the interface between exercise-responsive biology and incretin drug targets has never been mapped quantitatively. We conducted a dual-database bibliometric and knowledge-mapping analysis of Web of Science Core Collection and Scopus records (2005–2026) to describe (i) the collaboration structure of the field by author, institution and country; (ii) its intellectual base through document co-citation clustering; and (iii) its emerging fronts through keyword burst detection. Four thousand two hundred sixty unique articles were retained after screening and three-step deduplication. The co-citation network (3,203 nodes; 11,124 edges; modularity Q = 0.9358; weighted mean silhouette S = 0.9508) resolves into 18 clusters that consolidate into six mechanistically coherent thematic domains: exercise-responsive molecular and metabolic targets, pharmacological targets and exercise mimetics, multi-omics target discovery, exerkine secretion dynamics, drug–exercise interactions, and epigenetic–pancreatic endocrine targets. Eight keyword bursts consolidate into three emerging trends: outcome-oriented epidemiology, renal and haemodynamic endpoint validation, and lifestyle-integrated combination care. This registration freezes the search strings, inclusion and exclusion criteria, deduplication algorithm, entity-normalisation rules and analysis parameters; the analysis scripts are deposited with the registration. Registration type: Open-Ended Registration. Bibliographic data were retrieved on 10 October 2026 and the analyses were completed before this registration was submitted; the registration documents the research questions, data pipeline and analysis plan as implemented, and no analytic decision was modified after results were observed.

Authors

Publication Details

Journal
Open Science Framework
Published
2026-10-27
DOI
https://doi.org/10.17605/osf.io/hdj62
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exercise-Responsive Endocrine, Metabolic and Immune Drug Targets: A Dual-Database Bibliometric and Knowledge-Mapping Analysis

Liang Shuai
2 links
Open Science Framework
Diabetes Treatment and Management
article

Exercise-Responsive Endocrine, Metabolic and Immune Drug Targets: A Dual-Database Bibliometric and Knowledge-Mapping Analysis

Liang Shuai
article en

Abstract

Incretin-based pharmacotherapy — glucagon-like peptide-1 (GLP-1) receptor agonists, dual GIP/GLP-1 co-agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors — has reshaped the treatment of type 2 diabetes and obesity since 2005. Exercise acts on many of the same endocrine, metabolic and immune targets, yet the interface between exercise-responsive biology and incretin drug targets has never been mapped quantitatively. We conducted a dual-database bibliometric and knowledge-mapping analysis of Web of Science Core Collection and Scopus records (2005–2026) to describe (i) the collaboration structure of the field by author, institution and country; (ii) its intellectual base through document co-citation clustering; and (iii) its emerging fronts through keyword burst detection. Four thousand two hundred sixty unique articles were retained after screening and three-step deduplication. The co-citation network (3,203 nodes; 11,124 edges; modularity Q = 0.9358; weighted mean silhouette S = 0.9508) resolves into 18 clusters that consolidate into six mechanistically coherent thematic domains: exercise-responsive molecular and metabolic targets, pharmacological targets and exercise mimetics, multi-omics target discovery, exerkine secretion dynamics, drug–exercise interactions, and epigenetic–pancreatic endocrine targets. Eight keyword bursts consolidate into three emerging trends: outcome-oriented epidemiology, renal and haemodynamic endpoint validation, and lifestyle-integrated combination care. This registration freezes the search strings, inclusion and exclusion criteria, deduplication algorithm, entity-normalisation rules and analysis parameters; the analysis scripts are deposited with the registration. Registration type: Open-Ended Registration. Bibliographic data were retrieved on 10 October 2026 and the analyses were completed before this registration was submitted; the registration documents the research questions, data pipeline and analysis plan as implemented, and no analytic decision was modified after results were observed.

Open Science Framework
Good health and well-being
Openalex Percentile: Top 11%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon